Feng D - Search Results

1

Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.

Li X, Luo F, Li Q, Xu M, Feng D, Zhang G, Wu W. Li X, et al. Among authors: feng d. Oncol Rep. 2011 Dec;26(6):1431-9. doi: 10.3892/or.2011.1437. Epub 2011 Aug 24. Oncol Rep. 2011. PMID: 21874264

2

Identification of differentially expressed genes in rat silicosis model by suppression subtractive hybridization analysis.

Jin Z, Liu B, Feng D, Chen C, Li X, Hu Y, Peng J, Liu Y, Du J, Fu C, Wen J. Jin Z, et al. Among authors: feng d. Acta Biochim Biophys Sin (Shanghai). 2008 Aug;40(8):740-6. Acta Biochim Biophys Sin (Shanghai). 2008. PMID: 18685790

3

Silica Induces Plasminogen Activator Inhibitor-1 Expression through a MAPKs/AP-1-Dependent Mechanism in Human Lung Epithelial Cells.

Hu YB, Lin Z, Feng DY, Li X, Chu L, Jiang HY, Peng JW. Hu YB, et al. Among authors: feng dy. Toxicol Mech Methods. 2008 Jan;18(7):561-7. doi: 10.1080/15376510701795470. Toxicol Mech Methods. 2008. PMID: 20020854

4

Identification of aberrantly expressed miRNAs in rectal cancer.

Li X, Zhang G, Luo F, Ruan J, Huang D, Feng D, Xiao D, Zeng Z, Chen X, Wu W. Li X, et al. Among authors: feng d. Oncol Rep. 2012 Jul;28(1):77-84. doi: 10.3892/or.2012.1769. Epub 2012 Apr 20. Oncol Rep. 2012. PMID: 22576798

5

[Identification of aberrantly expressed miRNAs in rectal cancer].

Li X, Zhang G, Li Q, Xu M, Feng D, Wu W. Li X, et al. Among authors: feng d. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jul;37(7):662-8. doi: 10.3969/j.issn.1672-7347.2012.07.003. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22886225 Chinese.

6

MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.

Liu Y, Wu C, Wang Y, Wen S, Wang J, Chen Z, He Q, Feng D. Liu Y, et al. Among authors: feng d. Oncol Rep. 2014 Nov;32(5):1923-30. doi: 10.3892/or.2014.3424. Epub 2014 Aug 20. Oncol Rep. 2014. PMID: 25174729

7

Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.

Wen S, Liu Y, Yang M, Yang K, Huang J, Feng D. Wen S, et al. Among authors: feng d. Oncol Rep. 2016 Oct;36(4):2193-9. doi: 10.3892/or.2016.5009. Epub 2016 Aug 9. Oncol Rep. 2016. PMID: 27509921

8

Concomitant stromal tumor and early cancer of the stomach: What should be done?

Xu Y, Shen L, Lu Z, Liu X, Wu W, Feng D, Rao JN, Xiao L, Ouyang M. Xu Y, et al. Among authors: feng d. Medicine (Baltimore). 2017 Jul;96(29):e7576. doi: 10.1097/MD.0000000000007576. Medicine (Baltimore). 2017. PMID: 28723792 Free PMC article.

9

Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair.

Yin JY, Shen J, Dong ZZ, Huang Q, Zhong MZ, Feng DY, Zhou HH, Zhang JT, Liu ZQ. Yin JY, et al. Clin Cancer Res. 2011 Jul 1;17(13):4600-9. doi: 10.1158/1078-0432.CCR-10-2591. Epub 2011 May 24. Clin Cancer Res. 2011. PMID: 21610145 Free PMC article.

10

In vivo treatment of HCV core-positive HepG2 cells with the transfer of recombinant caspase-3 using a 2'-5' OAS promoter.

Zi Y, Wang Y, Wiegmann PS, Luo J, Feng D. Zi Y, et al. Among authors: feng d. Mol Med Rep. 2012 Mar;5(3):631-6. doi: 10.3892/mmr.2011.703. Epub 2011 Dec 9. Mol Med Rep. 2012. PMID: 22159511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,347 results

Search Page

Filters